10 Sands Capital 10x Genomics Trades
Sands Capital's position in 10x Genomics is currently worth $84.6 Million. That's 0.25% of their equity portfolio (50th largest holding). The investor owns 3.13% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q4 2021. Since then Sands Capital bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $344 Million, resulting in a loss of 75%.
News about 10x Genomics Inc - Ordinary Shares - Class A and Sands Capital
Top 5 Genomics Companies in the World
In this piece, we will take a look at the top five genomics companies in the world. For a detailed look at the genomics industry, check out Top 20 Genomics C...
ExodusPoint Capital Management LP buys $1.43 million worth of 10x Genomics, Inc. (NASDAQ:TXG) shares
ExodusPoint Capital Management LP Buys 39,250 Shares of 10x Genomics, Inc. (NASDAQ:TXG) Valued at $1,430,000 On June 11, 2023, it was reported that ExodusPoi...
Looking Into 10x Genomics''s Return On Capital Employed
Benzinga Pro data, 10x Genomics (NASDAQ: TXG ) reported Q1 sales of $134.28 million. Earnings fell to a loss of $50.75 million, resulting in a 194.78% decrea...
10x Genomics Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q3, 10x Genomics ''s (NASDAQ: TXG ) reported sales totaled $131.07 million. Despite a 34.97% increase in earnings...